Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Fukuyama

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|August 24, 2004
Osteoporosis requires bone-specific statinsMasao Koida, Ryo Fukuyama, Hiromichi Nakamuta
Heliyon|April 8, 2024
Effect of nattokinase on the pathological conditions in streptozotocin induced diabetic ratsMoe Yamaguchi, Ryo Fukuyama, Mitsugu Fujita
Journal of Cellular Biochemistry|September 16, 2004
Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2Takashi Fujita, Ryo Fukuyama, Hirayuki Enomoto, et al.
The Journal of Biological Chemistry|April 17, 2002
New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMPTakashi Fujita, Toru Meguro, Ryo Fukuyama, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2016
Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and StrengthTakeshi Moriishi, Ryo Fukuyama, Toshihiro Miyazaki, et al.
Biological & Pharmaceutical Bulletin|November 2, 2011
Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive ratsMitsugu Fujita, Katsunori Ohnishi, Shinsaku Takaoka, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Statins inhibit osteoblast migration by inhibiting Rac-Akt signalingRyo Fukuyama, Takashi Fujita, Yasutaka Azuma, et al.
The Journal of Cell Biology|July 1, 2004
Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signalingTakashi Fujita, Yasutaka Azuma, Ryo Fukuyama, et al.
Plos One|July 7, 2012
Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloadingTakeshi Moriishi, Ryo Fukuyama, Masako Ito, et al.
Journal of Pharmacological Sciences|May 25, 2011
Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulatorRyo Fukuyama, Akio Shimokawa, Yasushi Kodama, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|August 24, 2004
Osteoporosis requires bone-specific statinsMasao Koida, Ryo Fukuyama, Hiromichi Nakamuta
Heliyon|April 8, 2024
Effect of nattokinase on the pathological conditions in streptozotocin induced diabetic ratsMoe Yamaguchi, Ryo Fukuyama, Mitsugu Fujita
Journal of Cellular Biochemistry|September 16, 2004
Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2Takashi Fujita, Ryo Fukuyama, Hirayuki Enomoto, et al.
The Journal of Biological Chemistry|April 17, 2002
New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMPTakashi Fujita, Toru Meguro, Ryo Fukuyama, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2016
Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and StrengthTakeshi Moriishi, Ryo Fukuyama, Toshihiro Miyazaki, et al.
Biological & Pharmaceutical Bulletin|November 2, 2011
Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive ratsMitsugu Fujita, Katsunori Ohnishi, Shinsaku Takaoka, et al.
Biochemical and Biophysical Research Communications|February 21, 2004
Statins inhibit osteoblast migration by inhibiting Rac-Akt signalingRyo Fukuyama, Takashi Fujita, Yasutaka Azuma, et al.
The Journal of Cell Biology|July 1, 2004
Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signalingTakashi Fujita, Yasutaka Azuma, Ryo Fukuyama, et al.
Plos One|July 7, 2012
Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloadingTakeshi Moriishi, Ryo Fukuyama, Masako Ito, et al.
Journal of Pharmacological Sciences|May 25, 2011
Anti-osteoporosis effect of 5-bromo-2-(4-chlorobenzoyl)-(Z)-3-(2-cyano-3-hydroxybut-2-enonyl)aminobenzo[b]furan: a novel selective estrogen receptor modulatorRyo Fukuyama, Akio Shimokawa, Yasushi Kodama, et al.
Pageof 3